BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 19795464)

  • 1. Tumor-targeted intracellular delivery of anticancer drugs through the mannose-6-phosphate/insulin-like growth factor II receptor.
    Prakash J; Beljaars L; Harapanahalli AK; Zeinstra-Smith M; de Jager-Krikken A; Hessing M; Steen H; Poelstra K
    Int J Cancer; 2010 Apr; 126(8):1966-1981. PubMed ID: 19795464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mannose-6-phosphate/insulin-Like growth factor-II receptors may represent a target for the selective delivery of mycophenolic acid to fibrogenic cells.
    Greupink R; Bakker HI; van Goor H; de Borst MH; Beljaars L; Poelstra K
    Pharm Res; 2006 Aug; 23(8):1827-34. PubMed ID: 16850269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Albumin modified with mannose 6-phosphate: A potential carrier for selective delivery of antifibrotic drugs to rat and human hepatic stellate cells.
    Beljaars L; Molema G; Weert B; Bonnema H; Olinga P; Groothuis GM; Meijer DK; Poelstra K
    Hepatology; 1999 May; 29(5):1486-93. PubMed ID: 10216133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characteristics of the hepatic stellate cell-selective carrier mannose 6-phosphate modified albumin (M6P(28)-HSA).
    Beljaars L; Olinga P; Molema G; de Bleser P; Geerts A; Groothuis GM; Meijer DK; Poelstra K
    Liver; 2001 Oct; 21(5):320-8. PubMed ID: 11589768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of targeted liposomes with primary cultured hepatic stellate cells: Involvement of multiple receptor systems.
    Adrian JE; Poelstra K; Scherphof GL; Molema G; Meijer DK; Reker-Smit C; Morselt HW; Kamps JA
    J Hepatol; 2006 Mar; 44(3):560-7. PubMed ID: 16368158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel approach to deliver anticancer drugs to key cell types in tumors using a PDGF receptor-binding cyclic peptide containing carrier.
    Prakash J; de Jong E; Post E; Gouw AS; Beljaars L; Poelstra K
    J Control Release; 2010 Jul; 145(2):91-101. PubMed ID: 20362019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Redox-responsive mesoporous selenium delivery of doxorubicin targets MCF-7 cells and synergistically enhances its anti-tumor activity.
    Zhao S; Yu Q; Pan J; Zhou Y; Cao C; Ouyang JM; Liu J
    Acta Biomater; 2017 May; 54():294-306. PubMed ID: 28267598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of insulin-like growth factor II (IGF-II)-dependent cell growth by multidentate pentamannosyl 6-phosphate-based ligands targeting the mannose 6-phosphate/IGF-II receptor.
    Zavorka ME; Connelly CM; Grosely R; MacDonald RG
    Oncotarget; 2016 Sep; 7(38):62386-62410. PubMed ID: 27694692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dual actions of albumin packaging and tumor targeting enhance the antitumor efficacy and reduce the cardiotoxicity of doxorubicin in vivo.
    Zheng K; Li R; Zhou X; Hu P; Zhang Y; Huang Y; Chen Z; Huang M
    Int J Nanomedicine; 2015; 10():5327-42. PubMed ID: 26346331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mannose-6-phosphate/insulin-like growth factor II receptor expression and tumor development.
    Hébert E
    Biosci Rep; 2006 Feb; 26(1):7-17. PubMed ID: 16779663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective induction of apoptosis in MCF7 cancer-cell by targeted liposomes functionalised with mannose-6-phosphate.
    Minnelli C; Cianfruglia L; Laudadio E; Galeazzi R; Pisani M; Crucianelli E; Bizzaro D; Armeni T; Mobbili G
    J Drug Target; 2018 Mar; 26(3):242-251. PubMed ID: 28795851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human osteosarcoma (U-2 OS) cells express both insulin-like growth factor-I (IGF-I) receptors and insulin-like growth factor-II/mannose-6-phosphate (IGF-II/M6P) receptors and synthesize IGF-II: autocrine growth stimulation by IGF-II via the IGF-I receptor.
    Raile K; Höflich A; Kessler U; Yang Y; Pfuender M; Blum WF; Kolb H; Schwarz HP; Kiess W
    J Cell Physiol; 1994 Jun; 159(3):531-41. PubMed ID: 8188767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased expression of the mannose 6-phosphate/insulin-like growth factor-II receptor in breast cancer cells alters tumorigenic properties in vitro and in vivo.
    Lee JS; Weiss J; Martin JL; Scott CD
    Int J Cancer; 2003 Nov; 107(4):564-70. PubMed ID: 14520693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Doxorubicin-Bound Albumin Nanoparticles Containing a TRAIL Protein for Targeted Treatment of Colon Cancer.
    Thao le Q; Byeon HJ; Lee C; Lee S; Lee ES; Choi YW; Choi HG; Park ES; Lee KC; Youn YS
    Pharm Res; 2016 Mar; 33(3):615-26. PubMed ID: 26526555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel lipid-based drug carrier targeted to the non-parenchymal cells, including hepatic stellate cells, in the fibrotic livers of bile duct ligated rats.
    Adrian JE; Kamps JA; Scherphof GL; Meijer DK; van Loenen-Weemaes AM; Reker-Smit C; Terpstra P; Poelstra K
    Biochim Biophys Acta; 2007 Jun; 1768(6):1430-9. PubMed ID: 17493581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ethanol consumption decreases the synthesis of the mannose 6-phosphate/insulin-like growth factor II receptor but does not decrease its messenger RNA.
    Haorah J; MacDonald RG; Stoner JA; Donohue TM
    Biochem Pharmacol; 2003 Feb; 65(4):637-48. PubMed ID: 12566093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mannose-6-phosphate/insulin-like growth factor-II receptor in human melanoma cells: effect of ligands and antibodies on the receptor expression.
    Laube F
    Anticancer Res; 2009 Apr; 29(4):1383-8. PubMed ID: 19414391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis of a targeting drug for antifibrosis of liver; a conjugate for delivering glycyrrhetin to hepatic stellate cells.
    Zhang J; Zhang QS; Chen XM; Tian GY
    Glycoconj J; 2002 Jul; 19(6):423-9. PubMed ID: 14707489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhalable self-assembled albumin nanoparticles for treating drug-resistant lung cancer.
    Choi SH; Byeon HJ; Choi JS; Thao L; Kim I; Lee ES; Shin BS; Lee KC; Youn YS
    J Control Release; 2015 Jan; 197():199-207. PubMed ID: 25445703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Silencing the mannose 6-phosphate/IGF-II receptor differentially affects tumorigenic properties of normal breast epithelial cells.
    Caixeiro NJ; Martin JL; Scott CD
    Int J Cancer; 2013 Dec; 133(11):2542-50. PubMed ID: 23686499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.